Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Paula_Ragan
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
immunology
oncology rare diseases |
| gptkbp:foundedYear |
2014
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:mavorixafor
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:XFOR
|
| gptkbp:website |
https://www.x4pharma.com/
|
| gptkbp:bfsParent |
gptkb:Arsanis
|
| gptkbp:bfsLayer |
5
|
| http://www.w3.org/2000/01/rdf-schema#label |
X4 Pharmaceuticals
|